How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion. - Wikidata - wikimedia - TriplyDB

How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion.

How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion.

http://www.wikidata.org/entity/Q30688001

about

Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept Establishment of age- and sex-adjusted reference data for hand bone mass and investigation of hand bone loss in patients with rheumatoid arthritis treated in clinical practice: an observational study from the DANBIO registry and the Copenhagen Osteo Interpreting radiographic data in rheumatoid arthritis.Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial.Radiographic progression depicted by probability plots: presenting data with optimal use of individual values.Presentation and analysis of data on radiographic outcome in clinical trials: experience from the TEMPO study.Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: data from GENIRA.Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.Structural damage in rheumatoid arthritis as visualized through radiographs.Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis.Imaging: do erosions heal?Long term high intensity exercise and damage of small joints in rheumatoid arthritis Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months' follow up Infliximab in active early rheumatoid arthritis.Effective use of TNF antagonists.Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change.Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes.Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab.Comprehensive disease control (CDC): what does achieving CDC mean for patients with rheumatoid arthritis?Reporting of radiographic methods in randomised controlled trials assessing structural outcomes in rheumatoid arthritis.The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial.Developments in the clinical understanding of rheumatoid arthritis.Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol.Predictor of Hand Radiological Progression in Patients With Rheumatoid Arthritis Receiving TNF Antagonist Therapy by Change in Grayscale Synovitis-A Preliminary Study Protein kinase small molecule inhibitors for rheumatoid arthritis: Medicinal chemistry/clinical perspectives.Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial.Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis.Patients with rheumatoid arthritis in clinical care.Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone.Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction.From inhibition of radiographic progression to maintaining structural integrity: a methodological framework for radiographic progression in rheumatoid arthritis and psoriatic arthritis clinical trials.Efficacy and safety of certolizumab pegol plus methotrexate in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: the J-RAPID randomized, placebo-controlled trial.Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example.Measurement error in the assessment of radiographic progression in rheumatoid arthritis (RA) clinical trials: the smallest detectable change (SDC) revisited.Impact of patient-reported flares on radiographic progression and functional impairment in patients with rheumatoid arthritis: a cohort study based on the AMBRA trial.A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs.Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study.Efficacy and safety of certolizumab pegol without methotrexate co-administration in Japanese patients with active rheumatoid arthritis: the HIKARI randomized, placebo-controlled trial.

P2860

Q24804764-8604AD2B-090C-4BB6-8A19-973463B5BAEE Q28603734-6225534C-F53D-4579-B013-BC9A926A07BC Q30804224-1074148E-0AC0-41E9-9F54-0C851BE4D892 Q30812918-D4DA5E88-5C11-4E92-8627-0BBDA708A164 Q30912433-BCD05962-F47D-4471-9C79-C6A5F02242E1 Q30980061-8F356A2C-E1AD-4C72-9B64-1D3887BB6A51 Q31149663-B42D8602-6A2E-43C7-8202-9424CFD0CCE9 Q33708846-E7DA2DB4-CC9D-4AA9-881A-E5E285931FF6 Q34033218-47196051-5E17-4CCC-8CC3-0483D64FFAEF Q34731299-51CC886C-92D6-4C6E-A143-7B72517D9384 Q35552900-2119E1B3-24D4-40C3-92B6-600354C4ACD9 Q35553455-176E7467-C47B-43A1-8CBA-45A1AEF317BB Q35553467-B6F6B1D0-AE9F-4A2F-8B67-DF6C56813230 Q35553536-187D9DA7-883C-4C7C-94DA-12ABE7F0D10A Q35553834-4D7B46F7-5E30-441F-956A-EFDFA79573C0 Q35823650-E3306EB7-D167-46CE-9F08-75540E230B17 Q35851956-D5456D65-C4CA-4DC3-A896-AE87A8AAF221 Q35954535-4CE2DC15-7A73-46D0-B411-CC7616FDF355 Q35954629-50AAC022-928E-4F06-A492-4B906FD3F066 Q36374666-81A5CABE-AA8A-471A-AA68-FDA81508F689 Q36678766-2DEB0396-596F-4AA2-B53B-2CC61EF16795 Q36790324-4213F631-5ED5-43FE-B560-EB4365E3F29E Q37172820-6F8B19D9-1043-45A1-AF64-B776782788FD Q37207010-152F5BB9-FF3C-4A40-B498-DCCA8227007C Q37465379-971F7DE3-5420-47BC-A5C8-37F13312E0A1 Q37665060-D9A06C78-78A0-49E3-989F-C9C5D160B0A4 Q38251801-35D73EBB-DFA7-470A-9CD3-D4AFE5F3FAF4 Q40110226-E8AE4C73-3671-448C-84F0-88D410C7C927 Q40740817-C34E2E3E-8A81-4774-8E4F-3D73CCB02435 Q41828498-4F2EF439-F48D-4292-A342-EE0B17EAE1E1 Q42121483-4E7432C0-4AED-4C33-82C6-DB8B66D534FF Q42540679-1135485F-57AF-4623-B3B4-292119968AC1 Q45241079-880B43F2-5AFB-432B-BD9F-F57E6859CD62 Q46030948-70B95CE8-00E6-430B-973B-6CE5E57AE4D0 Q46394309-194B997D-A737-4955-9186-3BD47852A14C Q46397140-CB99180E-F094-4283-990F-F418B25439B3 Q47659402-43BF3D06-643F-435B-9229-E0BC168F399D Q47772154-BC371E32-3AC1-40A2-992E-88087EBB7A49 Q52595619-0DB72C53-89FE-4245-B101-2A11B65C007D Q54268275-DDC803A5-A59C-496E-88F3-B06DD66B90A2

P2860

How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion.

http://www.wikidata.org/entity/Q30688001

description

2002 nî lūn-bûn

@nan

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

How to report radiographic dat ...... from a roundtable discussion.

@ast

How to report radiographic dat ...... from a roundtable discussion.

@en

type

label

How to report radiographic dat ...... from a roundtable discussion.

@ast

How to report radiographic dat ...... from a roundtable discussion.

@en

prefLabel

How to report radiographic dat ...... from a roundtable discussion.

@ast

How to report radiographic dat ...... from a roundtable discussion.

@en

P1433

Q30688001-B3D73E43-5BFD-411D-99DF-13C8C45D3FF1

P1476

Q30688001-767A5AB1-84E8-4B97-AE53-ABCC15EC8F98

P2093

Q30688001-0985CCD7-D631-42C0-B376-330F2EE6FE86

Q30688001-10EC0DAE-19FC-444B-AA7F-56EFB241FB1B

Q30688001-37E5E370-CC9D-4A5E-92CC-FE6229798EEF

Q30688001-4A94D38D-A97B-4926-831A-C247DA3AD83D

Q30688001-56CC1C07-9FA8-4AE5-B975-6017749A459B

Q30688001-5724E372-E11E-4CEB-9B71-A1024F39948C

Q30688001-69C76E85-ACD9-4B51-BBFA-ABF3ACBDC381

Q30688001-7D05FBAA-F561-4D8E-BFB1-CEA2CC0DF694

Q30688001-89942247-152E-4407-AF92-B7C930017199

P2860

Q30688001-30422840-2D36-4818-B5F0-A371C7380E54

Q30688001-5C5A0F5C-1B34-4D10-ABA5-C4BF19F9BC22

Q30688001-95893019-3BF0-4450-9AA4-7B6BBF247EFA

P304

Q30688001-F243E5B2-1281-411F-B805-F52DD2215174

P31

Q30688001-1CE2329F-6935-453F-8CE0-5EFFBE1CACC3

P356

Q30688001-B971E230-AA16-45AB-8B67-C666D1115FEF

P433

Q30688001-09D9A88E-3C15-49F0-A78D-67A4155B93F7

P478

Q30688001-166FFCBD-346D-4EFD-8494-E2BD58A7FA75

P50

Q30688001-68D9FF70-14DA-4E9D-8D32-39C9B2E8B33F

Q30688001-71183ED0-7FDF-4D21-AE1D-F117AA0ACA1A

P577

Q30688001-E01CF505-2013-486F-B1DB-267D08306CAF

P5875

Q30688001-BFFDC17A-39EB-4DCC-8FC0-8538447117F2

P698

Q30688001-2835AF17-8EB5-491A-ACC7-75B063A2B0F0

P356

P1433

Arthritis & Rheumatology

P1476

How to report radiographic dat ...... from a roundtable discussion.

@en

P2093

Ferdinand Breedveld

http://www.w3.org/2001/XMLSchema#string

John Sharp

http://www.w3.org/2001/XMLSchema#string

Lee Simon

http://www.w3.org/2001/XMLSchema#string

Maarten Boers

http://www.w3.org/2001/XMLSchema#string

Michael Weinblatt

http://www.w3.org/2001/XMLSchema#string

Michael Weisman

http://www.w3.org/2001/XMLSchema#string

Peter Lipsky

http://www.w3.org/2001/XMLSchema#string

Rolf Rau

http://www.w3.org/2001/XMLSchema#string

Vibeke Strand

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical methods for assessing agreement between two methods of clinical measurement

Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.

How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?

P304

215-218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.10181

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

Désirée van der Heijde

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11413167

http://www.w3.org/2001/XMLSchema#string

P698

11954017

http://www.w3.org/2001/XMLSchema#string